These results indicate that A459 line is more sensitive for Cu(II)–MTX than CT26 cell line. It is noteworthy that all the tested compounds showed Selleck GSK2126458 a significantly better anticancer activity than cisplatin (Table 3). Selected photographs of CT26 and A549 cell lines treated with the tested compounds are provided in Fig. 8. Cell viability was examined by counting the dead and alive cells stained with two fluorescent dyes. Accordingly, green cells with normal nuclei were treated as viable cells (AO+), while the red ones as dead (PI+). As can be noticed, Cu(II)–MTX caused a significant reduction only in the surviving fraction of A549 cell line (after 24 h of incubation time). This means that the investigated

complex may exhibit selective biological activity Selumetinib datasheet toward only specific tumors. These studies indicate that Cu(II)–MTX exhibits biological activity toward specific cell lines and the cytotoxicity level is time dependent. The obtained results are preliminary

and further investigations are needed to understand the molecular mechanism of cytotoxicity. Table 3 IC50 values for MTX, CuCl2, Cu(II)–MTX, and cisplatin against CT26 and A549 cell lines after 4 and 24 h of incubation   IC50 values [μM]a 4 h 24 h CT26 A549 CT26 A549 MTX 258 ± 78 348 ± 32 460 ± 23 485 ± 12 CuCl2 360 ± 52 459 ± 32 423 ± 32 481 ± 11 Cu(II)–MTX 135 ± 17 151 ± 12 1022 ± 172 188 ± 52 Cisplatin 2200 ± 20 3150 ± 450 4990 ± 670 3850 ± 430 CP673451 IC50 = concentration of drug required to inhibit growth of 50 % of the cancer cells (Strohfeldt et al., 2008) aData are mean ± SD of three replicates each Fig. 8 The selected photos (magnification ×20.00, bar 50 µm) of CT26 and A549cells after treated with the tested compounds (0.05 mM) for 24 h. The green cells with normal morphology are viable ones (AO+), while round red cells are dead (PI+) Conclusions It was demonstrated that MTX interacts with Cu(II) ions and in aqueous solution it forms three monomeric complexes in a wide pH range. Moreover, basic biological in vitro studies were performed. In the presence of hydrogen peroxide the Cu(II)–MTX system displays nuclease activity,

almost completely cleaving DNA. Most probably, the responsibility for the plasmid degradation processes may be attributed to the copper-oxene or copper-coordinated hydroxyl radical. Investigations of the Bumetanide anticancer activity showed that the complex generally displays higher cytotoxicity in vitro than the ligand and metal ion separately and is more selective against A459 cell line. As MTX is used in the treatment of lung cancer, our investigations demonstrated that complexation of MTX by Cu(II) ions results in its higher cytotoxicity. Moreover, in comparison to cisplatin, the Cu(II)–MTX system shows superior anti-tumor effects. MTX interacts with copper(II) ions forming complexes which display high DNA-cleaving propensity and promising cytotoxicity.